How Menopause Changes Your Skin — A Physician's Guide

Menopause is not simply the end of menstruation. For the skin, it marks the beginning of a period of accelerated structural change that, left unaddressed, manifests as thinning, sagging, dryness, and a loss of the radiance most women associate with their younger years. As a physician specialising in menopause aesthetics in Edmonton, I want to offer you the scientific framework that underpins every conversation we have at London & Glow.

The Central Driver: Oestrogen Decline

Oestrogen receptors are found throughout the skin — in keratinocytes, fibroblasts, melanocytes, hair follicles, and sebaceous glands. This means that when circulating oestradiol falls — typically beginning in perimenopause in the mid-40s — almost every skin structure is affected simultaneously.

The decline is not gradual. In the first five years after the final menstrual period, the skin loses approximately 30% of its collagen content — a figure replicated in multiple biopsy studies and cited in current NICE and British Menopause Society guidance. After this initial precipitous fall, collagen continues to decline at around 2% per year for the following two decades (Rzepecki et al., 2019, Menopause Review).

Collagen: The Scaffold of Your Skin

Collagen provides the structural framework that keeps skin firm and resilient. Types I and III are the dominant dermal collagens; Type I in particular is the primary target of oestrogen-mediated regulation. Fibroblasts — the cells responsible for synthesising collagen — express oestrogen receptors and require oestrogen to maintain their productivity. As levels drop, fibroblast activity decreases, collagen synthesis slows, and the breakdown of existing collagen (via matrix metalloproteinases) begins to outpace production.

The practical consequence is measurable skin thinning. Dermal thickness decreases by roughly 1.1% per year in postmenopausal women not using hormone replacement therapy (Thornton, 2018, Dermato-Endocrinology). This is why menopausal skin often feels more fragile and bruises more easily — there is simply less structural matrix between the surface and the underlying vasculature.

Hyaluronic Acid and Moisture Retention

Alongside collagen loss, oestrogen deficiency significantly reduces the skin's capacity to retain water. Hyaluronic acid (HA) — a glycosaminoglycan that can hold up to 1,000 times its own weight in water — is synthesised by fibroblasts under oestrogenic stimulation. Post-menopausally, HA concentrations in the dermis fall, leading to the characteristic dryness and crepe-like texture many of my patients describe.

This is not simply surface dehydration addressable by applying a moisturiser. The reduction in HA is structural — it affects the turgor, plumpness, and bounce of the skin. This is one of the reasons topical hyaluronic acid serums, while beneficial for surface comfort, cannot replicate the effect of restoring dermal HA levels through other means.

Elastin and the Loss of Skin Recoil

Elastin fibres, responsible for the skin's ability to snap back after stretching, are also oestrogen-dependent. Post-menopausal skin shows both quantitative reduction in elastin content and qualitative degradation of existing fibres (Rzepecki et al., 2019, Menopause Review). The clinical result is that skin that was once resilient begins to take longer to return to its resting position — you may notice this when you gently pinch the skin on the back of your hand.

The Vascularity Changes

Oestrogen promotes dermal vascularity. Its decline leads to reduced blood flow to the skin, which affects both the skin's colour (contributing to the sallowness many women notice) and its capacity to heal and regenerate. Wound healing slows, and the skin becomes more vulnerable to UV damage because the oestrogen-mediated DNA repair mechanisms in keratinocytes are diminished.

Sebaceous Gland Activity

The sebaceous glands, which produce the sebum that lubricates and protects the skin surface, are also oestrogen-responsive. Post-menopausally, sebum production falls, contributing to dryness. In some women, however, relative androgenic predominance (as oestrogen falls more steeply than testosterone) leads to acne-like breakouts on the chin and jawline — a frustrating paradox of dry, acne-prone skin simultaneously.

Hair Follicle Changes

Thinning of scalp hair and increased terminal hair on the face are both direct consequences of the altered oestrogen-to-androgen ratio at menopause. Oestrogen normally extends the anagen (growth) phase of the hair cycle; its decline shortens this phase, leading to diffuse shedding. Conversely, the relative androgen excess can stimulate follicles on the face, chin, and upper lip.

What This Means Clinically

Understanding these mechanisms is essential to developing an effective treatment strategy. At London & Glow, our approach to menopause aesthetics in Edmonton is always rooted in the biology. We are not merely treating lines and wrinkles — we are addressing the upstream structural changes that produce them.

Treatment decisions must take into account the altered mechanical properties of menopausal skin, the reduced collagen scaffold, and the changes in hydration. This is why physician-led care matters: the same technique or product dose appropriate for skin with intact hormonal support may need to be adapted significantly for the post-menopausal patient.

In subsequent articles, we will explore specific treatment considerations — from how neuromodulators behave differently in menopausal skin, to how dermal fillers must be placed differently, to the evidence base for skincare ingredients that genuinely make a difference after 45.

References

• Rzepecki AK, et al. (2019). Estrogen-deficient skin: The role of topical therapy. Menopause Review, 18(1):57–65.
• Thornton MJ. (2018). Estrogens and aging skin. Dermato-Endocrinology, 5(2):264–70.
• Lephart ED. (2018). Skin aging and oxidative stress: Equol's anti-aging effects via biochemical and molecular mechanisms. Ageing Research Reviews, 31:36–54.
• British Menopause Society. (2022). Menopause and the skin: BMS consensus statement. Post Reproductive Health, 28(4):190–7.